投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------|------------------------|------------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 华商基金 陈恒、何奇峰 | | | 人员姓名 | | | | 时间 | 2015 年 11 月 | 25 日 10：30 至 12：30 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | 上市公司接待人 员姓名 | | 董秘兼财务负责人 田俊、证券事务代表兼证券总监 代四顺 | | 投资者关系活动 主要内容介绍 | 公司业务发 ...

Group 1: Investor Relations Activity Overview - The investor relations activity involved a specific audience survey and business development communication [2][3]. - The meeting took place on December 10, 2015, from 14:30 to 15:00 [3]. - The location of the meeting was the conference room of Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd. [3]. Group 2: Participants and Roles - The meeting was attended by representatives from China Life Asset Management Co., Ltd., including 邓晓倩 [1]. - The hosting company was represented by the securities affairs representative and securities director 代四顺, along with other securities department personnel [3]. Group 3: Meeting Content - The main focus of the meeting was on the company's business development [3]. - A record of questions and discussions from the on-site communication was maintained [3].

投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 编号：TG1512-003 | --- | --- | --- | |-----------------------------|-----------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 宝盈基金管理有限公司 段鹏程 | | | 人员姓名 | | | | 时间 | 2015 年 12 月 | 14 日 9 ：30 至 11： 00 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | | | | | 上市公司接待人 | | 董秘兼财务负责人 田俊、证券事务代表兼证券总监 代 ...

Group 1: E-commerce Development - The company plans to leverage BW and HANA big data platforms to enhance e-commerce operations through data collection, analysis, and consumer behavior prediction [1] - Implementation of a CRM system aims to manage customer lifecycles and improve customer loyalty for both online and offline channels [1] - The logistics center will undergo technological upgrades to integrate store delivery and e-commerce services, enhancing logistics competitiveness [1] - The company aims to establish a vertical website focused on health products and services, utilizing an O2O model to strengthen online and offline business [1] Group 2: Market Expansion Strategy - The primary market is currently in the Southwest region, with additional presence in Hainan, Shanxi, Shanghai, and Tianjin [1] - Future development will focus on refining existing markets while gradually expanding into less competitive regions like Hainan and Shanxi [1] Group 3: Membership Management - The company has cultivated a stable member base in existing store markets, supported by a dedicated membership management system [2] - Strong member relationships have resulted in high brand loyalty and significant consumer retention [2] - The ongoing implementation of a CRM system will enhance customer data management and support marketing and sales decisions [3] Group 4: Professional Talent Development - The company actively recruits licensed pharmacists and conducts training programs to enhance the skills of existing employees [4] - Recent efforts in training and recruitment have yielded positive results in developing professional talent within the pharmacy sector [4]

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2015 年 12 月 30 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：电话访谈交流 投资者：国泰君安、中信证券、东北证券、兴业证券等 接待人：公司董事、 董事会秘书、副总裁、财务负责人 田俊 参加人员：证券事务代表兼证券总监代四顺、证券副总监李正红、财 务副总监肖冬磊、证券中心副经理卢国凤、证券事务主管王斌、证券 事务高级管理员田珂源 丁丹： 尊敬的各位投资者大家上午好，非常感谢大家在百忙之中抽出 时间参加国泰君安医药-一心堂定增方案调整解读电话会议，我是国 泰君安丁丹。众所周知，一心堂此次定增方案调整已公告相关事项。 为了让我们的投资者更好的了解公司的经营情况，我们特意邀请公 司领导董事会秘书田俊田总与各位投资者进行交流。 首先我们请一心堂董事会秘书兼财务负责人田俊田总解读此次 定增方案的调整的重要事项及其他相关情况，后续会留出时间给各 位投资者进行提问交流。 田总： 尊敬的各位参会投资者大家上午好，我是一心堂董秘兼 CFO 田 俊，首先我将本次定增方案及目前公司的基本概况向大家介绍下。 中国零售药店市场发展将会跟美 ...

Group 1: Investor Relations Activity - The activity involved a specific audience survey conducted by Guangfa Fund, represented by Qiu Jingmin [1] - The meeting took place on November 13, 2014, from 21:00 to 21:45 [1] - The location of the meeting was the conference room of Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd. [1] Group 2: Company Representatives - The meeting was attended by the company’s Secretary and Vice President, Tian Jun, and the Deputy Accounting Director, Li Zhenghong [1] Group 3: Main Content of the Activity - The primary focus of the investor relations activity was to discuss the company's business development [1]

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2014 年 12 月 03 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：现场交流 投资者：三菱日联证券控股股份有限公司中国业务总管永田哲也、 研究员王丹、公益社团法人佐治信行等 3 人 接待人：董秘兼副总裁 田俊 参加人员：证券事务代表兼证券总监 代四顺、会计副总监 肖冬磊、 投关部副经理 阴贯香 问题一，公司什么时间成立及何时改制为股份有限公司？ 答：公司系由成立于2000年11月8日的云南鸿翔药业有限公司整体变更设立。2009年5 月10日，经股东会批准，鸿翔药业整体变更为股份有限公司。 问题二，公司门店主要分布情况？ 答：截止2014年9月30日，我们有直营连锁门店2,480家，其中云南1,915家、四川141家、 广西254家、重庆38家、山西42家、贵州90家，首先公司将按预期完成募投开店计划。 问题三，新开门店的销售增长情况如何? 答： 我们在招股书上有过披露，按历史数据来看，我们每开一个门店，基本能保证一定 时间的持续增长，增长比例按城市、地域、位置等不同会有所差异。至经营满六年，店均收入仍 保持持续增长态 ...

Group 1: Store Growth and Market Expansion - The slowdown in store growth in the first half of 2014 was due to the delay in the implementation of the new GSP certification standards, which affected new store approvals [2] - As of September 30, 2014, the company had 2,480 directly-operated stores, with the majority located in Yunnan (1,915), followed by Guangxi (254), Sichuan (141), and others [2][3] - The company expects to complete its planned store openings as the new GSP standards are implemented [2] Group 2: Sales Performance and Profitability - New stores typically achieve profitability within 12 months, with cumulative profits offsetting initial losses [2] - The average revenue per store continues to grow over time, although the growth rate may decline after six years of operation [2] - The company has established strong partnerships with suppliers, enhancing its marketing capabilities and improving gross margins [3][4] Group 3: Brand Co-Building and Financial Impact - The brand co-building model enhances the company's market position and brand recognition through private label products [4] - This model has positively impacted sales revenue and overall gross margin, contributing to increased profitability [4] Group 4: Rural Market Development - Government investments in rural healthcare are expected to boost personal healthcare spending among rural populations, which is currently lower than in urban areas [5] - The number of rural stores has increased from 160 in 2011 to 390 by September 2014, with retail revenue growing from 13,276.25 thousand yuan in 2011 to 28,529.17 thousand yuan in 2014 [6] - The rural market represents a significant growth opportunity for the company, especially as urbanization trends continue [6]

投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 编号：TG1505-001 | --- | --- | --- | |------------------------|-------------------------------|------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | ■ 其他 （电话会议） | | | 参与单位名称及 | 兴业证券等 164 | 人 | | 人员姓名 | | | | 时间 | 2015 年 5 月 | 20 日 15：00-17 ： 00 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | 上市公司接待人 | | 公司董事、 董事会秘书、副总裁、财务负责人 田俊 | | 员姓名 | 证券事务代表、证券总监 代四顺 | | | ...

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2015 年 3 月 10 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：现场交流 投资者： 天弘基金郭相博、天弘基金刘盟盟、景林资产李朝、银 河证券李平祝、IDG 资本彭世泽、重阳投资胡敏、华泰证券何结领、李 璟、大禹投资黎仕禹、朱雀投资张皓、汇添富基金陈漳斌、兴业全球杨 世进、广发证券赵伟、中国人寿资产管理有限公司赵文龙、润晖投资 平晓川、王国进、国金证券姜英、信达证券孟阳、东方港湾凌军、上海 申银万国研究生周子露、长信基金陈益凌、华润元大基金张磊、上海 朴石投资毕海委、招商证券李勇、兴业证券邓晓倩、华夏基金邓湘伟、 冠亚集团陈真、溪牛投资管理周婷、中国银河证券霍辰伊、广州金骏 投资胡朝昀、上海铵盈投资杨海斌 接待人：董秘兼副总裁 田俊 参加人员: 董事长 阮鸿献、总裁 赵飚、副总裁 周红云、副总裁 伍 永军、董秘兼副总裁 田俊、证券事务代表兼证券总监 代四顺 问题一，公司电商业务的整体规划及核心竞争力是什么？ 答：电商业务的发展离不开强大的信息化基础支撑，截止现在，公司在信息化基础的 建设上已经累计投入超过 8000 ...